Internal Medicine, Endocrinology, Diabetes, & Metabolism · Albuquerque, NM
NPI
1578624631
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
8300 Constitution Ave NE, Pmg Endocrinology
Albuquerque, NM, 87110
Phone (505) 559-6400
Groups this clinician bills Medicare through
Medicare paid, 2024
$52K
1,120 services
Medicare patients, 2024
468
Average age 73
Drug cost, 2024
$1.9M
8,997 prescriptions
Company payments, 2025
$626
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by May O Reyes was code 99214 (office e&m - established), 508 times for 388 patients. In total May O Reyes billed 1,120 services in 11 codes, and Medicare paid $52K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-08-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 508 | 388 | $64.64 | $33K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 366 | 326 | $12.18 | $4,458 |
| 95251 Test - Miscellaneous | Facility | 82 | 58 | $25.60 | $2,099 |
| 99215 Office E&M - Established | Facility | 47 | 38 | $108.57 | $5,103 |
| 99213 Office E&M - Established | Facility | 33 | 33 | $50.67 | $1,672 |
| 99204 Office E&M - New | Facility | 19 | 19 | $79.78 | $1,516 |
| 99214 Office E&M - Established | Office | 17 | 17 | $88.43 | $1,503 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 15 | 15 | $12.64 | $190 |
By year: 2022 $45K for 681 services; 2023 $49K for 768 services; 2024 $52K for 1,120 services.
Medicare prescription drug claims, 2024
In 2024, the drug May O Reyes prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,889 prescriptions and refills. In total May O Reyes wrote 8,997 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,889 | 4,741 | 488 | $26K |
| Synthroid Levothyroxine Sodium | 375 | 890 | 90 | $31K |
| Alendronate Sodium Generic | 310 | 594 | 75 | $3,208 |
| Ozempic Semaglutide | 290 | 355 | 49 | $284K |
| Metformin Hcl Generic | 276 | 719 | 77 | $3,745 |
| Levoxyl Levothyroxine Sodium | 259 | 518 | 54 | $12K |
| Atorvastatin Calcium Generic | 245 | 664 | 74 | $3,478 |
| Farxiga Dapagliflozin Propanediol | 204 | 340 | 39 | $186K |
| Simvastatin Generic | 204 | 571 | 58 | $2,739 |
| Metformin Hcl Er Metformin Hcl | 203 | 586 | 72 | $3,390 |
| Lisinopril Generic | 193 | 561 | 58 | $2,281 |
| Trulicity Dulaglutide | 190 | 261 | 49 | $251K |
| Insulin Glargine-Yfgn Generic | 165 | 300 | 46 | $22K |
| Losartan Potassium Generic | 149 | 439 | 48 | $2,110 |
| Mounjaro Tirzepatide | 144 | 179 | 23 | $185K |
Brand drugs: 4,017 claims; generic drugs: 4,506 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid May O Reyes $626 ($626 in general payments such as food, travel and fees) from 14 companies. The largest payer was Amgen Inc. with $109.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 6 | $109 |
| Abbott Laboratories ABT | 4 | $83.97 |
| Novo Nordisk Inc NVO | 4 | $80.72 |
| Insulet Corporation PODD | 3 | $70.72 |
| Lilly USA, LLC LLY | 3 | $60.93 |
| Dexcom, Inc. DXCM | 2 | $37.9 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34.82 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $34.62 |
| Xeris Pharmaceuticals, Inc. | 1 | $22.59 |
| Acella Pharmaceuticals, LLC | 1 | $20.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.